CD16+CD57- natural killer cells in multifocal motor neuropathy.
We analyzed the CD16+CD57- lymphocyte subset, which is considered to have strong natural killer (NK) cell activity, in peripheral blood from patients with chronic immune-mediated neuropathies and patients with other neurological diseases. We found that the ratio of CD16+CD57- NK cells to total lymphocytes was increased in 4 of 6 patients with multifocal motor neuropathy (MMN) with persistent conduction block. Since the CD16 molecule is an Fc receptor for immunoglobulin G (IgG), high-dose intravenous immunoglobulin (IVIg) may interfere with CD16+CD57- NK cells via Fc receptor blockade. In addition, cyclophosphamide (Cy) is often used to suppress NK cells. Therefore, our findings may partly account for the effectiveness of IVIg or Cy, which is the current treatment of choice for MMN.
Mizutani
K
K
Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Oka
N
N
Kaji
R
R
Matsui
M
M
Asanuma
K
K
Kubori
T
T
Kojima
Y
Y
Kanda
M
M
Kawanishi
T
T
Tomimoto
H
H
Akiguchi
I
I
Shibasaki
H
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018959:CD57 Antigens / Q000276:immunology / Q000378:metabolism*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D016131:Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011115:Polyneuropathies / Q000276:immunology* / Q000378:metabolism; D017452:Receptors, IgG / Q000276:immunology / Q000378:metabolism*
D018959:CD57 Antigens; D017452:Receptors, IgG